Physician Wealth Advisors’s Axsome Therapeutics AXSM Stock Holding History

Physician Wealth Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.18K	Buy	17 +2	+13%	+$434	﹤0.01%	1178
2026 Q1	$2.55K	Buy	15 +3	+25%	+$518	﹤0.01%	1246
2025 Q4	$2.2K	Buy	12 +2	+20%	+$279	﹤0.01%	1242
2025 Q3	$1.22K	Sell	10 -4	-29%	-$451	﹤0.01%	1455
2025 Q2	$1.47K	Buy	14 +4	+40%	+$424	﹤0.01%	1172
2025 Q1	$1.17K	Hold	10	–	–	﹤0.01%	987
2024 Q4	$852	Buy	+10	New	+$920	﹤0.01%	978

Other funds holding AXSM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Physician Wealth Advisors's AXSM Position: Q2 2026 in Review

Physician Wealth Advisors increased its Axsome Therapeutics (AXSM) stake by 13% in Q2 2026, buying an estimated $434 and bringing the position to 17 shares worth $4.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

Physician Wealth Advisors first reported a position in AXSM in Q4 2024 and has held it in 7 quarters since. 120 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Physician Wealth Advisors held 17 shares of Axsome Therapeutics worth $4.18K as of Q2 2026.
Physician Wealth Advisors bought 2 Axsome Therapeutics shares in Q2 2026, an estimated $434.
Axsome Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1178 holding.
Physician Wealth Advisors first reported a position in Axsome Therapeutics in Q4 2024 and has held it in 7 quarters since.
120 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.